Literature DB >> 18654857

Novel mechanisms of protein synthesis in diabetic nephropathy--role of mRNA translation.

B S Kasinath1, M M Mariappan, K Sataranatarajan, M J Lee, G Ghosh Choudhury, D Feliers.   

Abstract

Ambient protein levels are affected by both synthesis and degradation. Synthesis of a protein is regulated by transcription and messenger RNA (mRNA) translation. Translation has emerged as an important site of regulation of protein expression during development and disease. It is under the control of distinct factors that regulate initiation, elongation and termination phases. Regulation of translation occurs via signaling reactions, guanosine diphosphate-guanosine triphosphate binding and by participation of non-coding RNA species such as microRNA. Recent work has revealed an important role for translation in hypertrophy, matrix protein synthesis, elaboration of growth factors in in vivo and in vitro models of diabetic nephropathy. Studies of translation dysregulation in diabetic nephropathy have enabled identification of novel therapeutic targets. Translation of mRNA is a fertile field for exploration in investigation of kidney disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18654857      PMCID: PMC5886780          DOI: 10.1007/s11154-008-9091-3

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  81 in total

Review 1.  Role of angiotensin II in diabetic nephropathy.

Authors:  D J Leehey; A K Singh; N Alavi; R Singh
Journal:  Kidney Int Suppl       Date:  2000-09       Impact factor: 10.545

2.  Angiotensin II stimulation of VEGF mRNA translation requires production of reactive oxygen species.

Authors:  Denis Feliers; Yves Gorin; Goutam Ghosh-Choudhury; Hanna E Abboud; Balakuntalam S Kasinath
Journal:  Am J Physiol Renal Physiol       Date:  2005-10-25

3.  G1 kinases and transforming growth factor-beta signaling are associated with a growth pattern switch in diabetes-induced renal growth.

Authors:  H C Huang; P A Preisig
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

4.  Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats.

Authors:  Núria Lloberas; Josep M Cruzado; Marcella Franquesa; Immaculada Herrero-Fresneda; Joan Torras; Gabriela Alperovich; Inés Rama; August Vidal; Josep M Grinyó
Journal:  J Am Soc Nephrol       Date:  2006-04-05       Impact factor: 10.121

5.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.

Authors:  Konrad T Howitz; Kevin J Bitterman; Haim Y Cohen; Dudley W Lamming; Siva Lavu; Jason G Wood; Robert E Zipkin; Phuong Chung; Anne Kisielewski; Li-Li Zhang; Brandy Scherer; David A Sinclair
Journal:  Nature       Date:  2003-08-24       Impact factor: 49.962

6.  Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase.

Authors:  D P Hanger; K Hughes; J R Woodgett; J P Brion; B H Anderton
Journal:  Neurosci Lett       Date:  1992-11-23       Impact factor: 3.046

7.  Renal enlargement: comparative autoradiographic studies of 3H-thymidine uptake in diabetic and uninephrectomized rats.

Authors:  R Rasch; J O Nörgaard
Journal:  Diabetologia       Date:  1983-09       Impact factor: 10.122

8.  Inhibition of glycogen synthase kinase 3beta activity regulates proliferation of cultured cerebellar granule cells.

Authors:  H Cui; Y Meng; R F Bulleit
Journal:  Brain Res Dev Brain Res       Date:  1998-12-07

Review 9.  Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models.

Authors:  B Viollet; F Andreelli; S B Jørgensen; C Perrin; D Flamez; J Mu; J F P Wojtaszewski; F C Schuit; M Birnbaum; E Richter; R Burcelin; S Vaulont
Journal:  Biochem Soc Trans       Date:  2003-02       Impact factor: 5.407

Review 10.  The mRNA cap-binding protein eIF4E in post-transcriptional gene expression.

Authors:  Tobias von der Haar; John D Gross; Gerhard Wagner; John E G McCarthy
Journal:  Nat Struct Mol Biol       Date:  2004-06       Impact factor: 15.369

View more
  12 in total

Review 1.  Regulation of mRNA translation in renal physiology and disease.

Authors:  Balakuntalam S Kasinath; Denis Feliers; Kavithalakshmi Sataranatarajan; Goutam Ghosh Choudhury; Myung Ja Lee; Meenalakshmi M Mariappan
Journal:  Am J Physiol Renal Physiol       Date:  2009-06-17

2.  PRAS40 acts as a nodal regulator of high glucose-induced TORC1 activation in glomerular mesangial cell hypertrophy.

Authors:  Nirmalya Dey; Nandini Ghosh-Choudhury; Falguni Das; Xiaonan Li; Balachandar Venkatesan; Jeffrey L Barnes; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

Review 3.  Emerging roles of RNA-binding proteins in diabetes and their therapeutic potential in diabetic complications.

Authors:  Curtis A Nutter; Muge N Kuyumcu-Martinez
Journal:  Wiley Interdiscip Rev RNA       Date:  2017-12-27       Impact factor: 9.957

4.  TGFβ enforces activation of eukaryotic elongation factor-2 (eEF2) via inactivation of eEF2 kinase by p90 ribosomal S6 kinase (p90Rsk) to induce mesangial cell hypertrophy.

Authors:  Falguni Das; Nandini Ghosh-Choudhury; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  FEBS Lett       Date:  2010-09-17       Impact factor: 4.124

5.  microRNA-181a downregulates deptor for TGFβ-induced glomerular mesangial cell hypertrophy and matrix protein expression.

Authors:  Soumya Maity; Amit Bera; Nandini Ghosh-Choudhury; Falguni Das; Balakuntalam S Kasinath; Goutam Ghosh Choudhury
Journal:  Exp Cell Res       Date:  2018-02-01       Impact factor: 3.905

6.  Combined acute hyperglycemic and hyperinsulinemic clamp induced profibrotic and proinflammatory responses in the kidney.

Authors:  Meenalakshmi M Mariappan; Kristin DeSilva; Gian Pio Sorice; Giovanna Muscogiuri; Fabio Jimenez; Seema Ahuja; Jefferey L Barnes; Goutam Ghosh Choudhury; Nicolas Musi; Ralph DeFronzo; Balakuntalam S Kasinath
Journal:  Am J Physiol Cell Physiol       Date:  2013-10-09       Impact factor: 4.249

7.  Erk in kidney diseases.

Authors:  Denis Feliers; Balakuntalam S Kasinath
Journal:  J Signal Transduct       Date:  2011-04-07

Review 8.  Signaling mechanisms in the regulation of renal matrix metabolism in diabetes.

Authors:  Meenalakshmi M Mariappan
Journal:  Exp Diabetes Res       Date:  2012-02-19

9.  Erlotinib can halt adenine induced nephrotoxicity in mice through modulating ERK1/2, STAT3, p53 and apoptotic pathways.

Authors:  Ahmed M Awad; Mohamed A Saleh; Nashwa M Abu-Elsaad; Tarek M Ibrahim
Journal:  Sci Rep       Date:  2020-07-13       Impact factor: 4.379

Review 10.  Surviving hypoxia by modulation of mRNA translation rate.

Authors:  Michael Fähling
Journal:  J Cell Mol Med       Date:  2009-08-08       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.